Cargando…

Serum miR-342-3p Acts as a Biomarker for Systemic Lupus Erythematosus and Participates in the Disease Progression

PURPOSE: The aim of this study was to investigate the diagnostic ability and prognostic value of miR-342-3p in SLE patients by detecting the expression level of serum miR-342-3p in SLE patients. PATIENTS AND METHODS: The expression level of serum miR-342-3p in all subjects was determined by qRT-PCR...

Descripción completa

Detalles Bibliográficos
Autores principales:	You, Min, Zhang, Long, Ding, Junxiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9829984/ https://www.ncbi.nlm.nih.gov/pubmed/36636634 http://dx.doi.org/10.2147/CCID.S378985

Ejemplares similares

Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia
por: Fayyad-Kazan, Hussein, et al.
Publicado: (2013)

Circulating miR-92a, miR-143 and miR-342 in Plasma are Novel Potential Biomarkers for Acute Myeloid Leukemia
por: Elhamamsy, Amr Rafat, et al.
Publicado: (2017)

Circ_0006220 Contributes to NSCLC Progression through miR-342-3p/GOT2 Axis
por: Tang, Jichun, et al.
Publicado: (2022)

Downregulation of miR-342 is associated with tamoxifen resistant breast tumors
por: Cittelly, Diana M, et al.
Publicado: (2010)

miR-342-3p Inhibits Acute Myeloid Leukemia Progression by Targeting SOX12
por: Wang, Ying, et al.
Publicado: (2022)

Regulation of microRNA in systemic lupus erythematosus: the role of miR-21 and miR-210
por: Kourti, Maria, et al.
Publicado: (2020)

miR-342-3p Regulates the Proliferation and Apoptosis of NSCLC Cells by Targeting BCL-2
por: Chen, Zhongjie, et al.
Publicado: (2021)

Tumor Suppressive Role of miR-342-5p and miR-491-5p in Human Osteosarcoma Cells
por: Veys, Clément, et al.
Publicado: (2022)

miR-342 inhibits glioma cell proliferation by targeting GPRC5A
por: Wang, Jianjiao, et al.
Publicado: (2019)

Tumor-derived circulating exosomal miR-342-5p and miR-574-5p as promising diagnostic biomarkers for early-stage Lung Adenocarcinoma
por: Han, Zhijun, et al.
Publicado: (2020)

Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease
por: Montag, Judith, et al.
Publicado: (2009)

An integrative genomic approach reveals coordinated expression of intronic miR-335, miR-342, and miR-561 with deregulated host genes in multiple myeloma
por: Ronchetti, Domenica, et al.
Publicado: (2008)

miR-342 is associated with estrogen receptor-α expression and response to tamoxifen in breast cancer
por: HE, YUE-JUN, et al.
Publicado: (2013)

Metadherin is an apoptotic modulator in prostate cancer through miR-342-3p regulation
por: Hu, Kebang, et al.
Publicado: (2018)

Life factors acting on systemic lupus erythematosus
por: Chen, Jiaxuan, et al.
Publicado: (2022)

miR-148b-3p, miR-190b, and miR-429 Regulate Cell Progression and Act as Potential Biomarkers for Breast Cancer
por: Dai, Wenzhu, et al.
Publicado: (2019)

miR-342 Regulates BRCA1 Expression through Modulation of ID4 in Breast Cancer
por: Crippa, Elisabetta, et al.
Publicado: (2014)

Epigenetic silencing of miR-342-3p in B cell lymphoma and its impact on autophagy
por: Zhang, Min Yue, et al.
Publicado: (2020)

New insights into the fascinating world of glucocorticoids: the dexamethasone-miR-342-Rictor axis in regulatory T cells
por: Buttgereit, Frank, et al.
Publicado: (2021)

Circular RNA circLOC101928570 suppresses systemic lupus erythematosus progression by targeting the miR-150-5p/c-myb axis
por: Zhao, Xingwang, et al.
Publicado: (2022)

Interaction of miR-181b and IFNA1 Polymorphisms on the Risk of Systemic Lupus Erythematosus
por: He, Yong-Ling, et al.
Publicado: (2020)

miR-183-5p Is a Potential Molecular Marker of Systemic Lupus Erythematosus
por: Zhou, Shaolan, et al.
Publicado: (2021)

Aberrantly reduced expression of miR-342-5p contributes to CCND1-associated chronic myeloid leukemia progression and imatinib resistance
por: Wu, Yi-Ying, et al.
Publicado: (2021)

Identification of MIR600HG/hsa-miR-342-3p/ANLN network as a potential prognosis biomarker associated with lmmune infiltrates in pancreatic cancer
por: Qian, Baolin, et al.
Publicado: (2023)

Tumor Suppressive Role of miR-342-5p in Human Chondrosarcoma Cells and 3D Organoids
por: Veys, Clément, et al.
Publicado: (2021)

miR-342-5p promotes Zmpste24-deficient mouse embryonic fibroblasts proliferation by suppressing GAS2
por: Zhang, Chun-Long, et al.
Publicado: (2017)

High serum leptin and adiponectin levels as biomarkers of disease progression in Egyptian patients with active systemic lupus erythematosus
por: Kamel, Shaimaa M, et al.
Publicado: (2023)

Serum circulating miRNA‐342‐3p as a potential diagnostic biomarker in parathyroid carcinomas: A pilot study
por: Krupinova, Julia, et al.
Publicado: (2021)

Corrigendum to “miR-183-5p Is a Potential Molecular Marker of Systemic Lupus Erythematosus”
por: Zhou, Shaolan, et al.
Publicado: (2021)

Crosstalk between miR-146a and pro-inflammatory cytokines in patients with systemic lupus erythematosus
por: El-Akhras, Basima A, et al.
Publicado: (2023)

Downregulated Serum Exosomal miR-451a Expression Correlates With Renal Damage and Its Intercellular Communication Role in Systemic Lupus Erythematosus
por: Tan, Lina, et al.
Publicado: (2021)

LncRNA LINC01503 aggravates the progression of cervical cancer through sponging miR-342-3p to mediate FXYD3 expression
por: Peng, Xing, et al.
Publicado: (2020)

Long Noncoding RNA LINC00460 Promotes Hepatocellular Carcinoma Progression via Regulation of miR-342-3p/AGR2 Axis
por: Yang, Jing, et al.
Publicado: (2020)

Terbinafine Induced Lupus Erythematosus With Progression to Lupus Nephritis
por: Hindosh, Naif, et al.
Publicado: (2022)

Elevated Serum miR-7, miR-9, miR-122, and miR-141 Are Noninvasive Biomarkers of Acute Pancreatitis
por: Lu, Pan, et al.
Publicado: (2017)

MiR-34a, miR-21 and miR-23a as potential biomarkers for coronary artery disease: a pilot microarray study and confirmation in a 32 patient cohort
por: Han, Hui, et al.
Publicado: (2015)

MiR-34a and miR-206 act as novel prognostic and therapy biomarkers in cervical cancer
por: Chen, Ai-Hua, et al.
Publicado: (2017)

microRNA-342-5p and miR-608 inhibit colon cancer tumorigenesis by targeting NAA10
por: Yang, Hongju, et al.
Publicado: (2015)

miR-342-5p Regulates Neural Stem Cell Proliferation and Differentiation Downstream to Notch Signaling in Mice
por: Gao, Fang, et al.
Publicado: (2017)

TNF-alpha-induced microglia activation requires miR-342: impact on NF-kB signaling and neurotoxicity
por: Brás, João Paulo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_g5a44n4c3i2ib3q7c64te6k43d